Can the Affects Conveyed by Baroque Music Reduce Anxiety in Patients With Major Depressive Disorder ?
BARHEPSY
2 other identifiers
interventional
18
1 country
1
Brief Summary
Major depressive disorder, or characterized depressive episode, is a common illness that limits psychosocial functioning and impairs quality of life. The initial goal of treatment for a major depressive episode is complete remission of depressive symptoms. The most commonly used treatments are antidepressants, psychotherapy or a combination of medication and psychotherapy. Music therapy can be considered as one of the complementary therapies in the treatment of the characterized depressive episode and many studies have shown a beneficial effect of musical interventions, even of short duration, on depression and anxiety. In depressive disorders, therapies such as hypnosis or phenomenological psychotherapies lead to modifications of consciousness during which the subject finds the means, notably non-reflexive and in the realm of the imaginary, to overcome anxiety. Generally speaking, in the field of musical cognition, it is considered that music affects the emotions. Unfortunately this approach is often insufficiently refined in cognitive psychology since it is most generally interested in the 6 fundamental emotions: joy, anger, fear, sadness, surprise, disgust. However, during the Baroque period (end of the 16th and 17th centuries), various philosophers and musicians analyzed with great finesse not these fundamental emotions, but more precisely the passions, or "shocks of the soul", that is to say the affects in their great diversity. These affects or passions are thus at the center of Baroque musical composition. In the Barhepsy project, it is suggested that listening to Baroque music, thanks to the rhetoric of the passions included in it, would allow the mobilization of the patients' affects and thus reduce their state of anxiety. During a follow-up consultation, the effects of a 30-minute "musical path" of baroque pieces will be evaluated, exemplifying the reduction of anxiety and the subsequent appeasement, on the conscious experience of subjects suffering from a characterized depressive state associated with anxious symptoms.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable major-depressive-disorder
Started May 2021
Shorter than P25 for not_applicable major-depressive-disorder
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 19, 2021
CompletedFirst Posted
Study publicly available on registry
May 26, 2021
CompletedStudy Start
First participant enrolled
May 28, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 17, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
February 17, 2022
CompletedApril 13, 2026
April 1, 2026
9 months
May 19, 2021
April 10, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Anxiety assessed by State Trait Anxiety Inventory questionnaire
the minimum value is 20 and the maximum value is 80. Higher scores mean a worse outcome, high level of anxiety.
1 day
Secondary Outcomes (3)
Qualitative assessment scale of the fluency of consciousness (EQFC)
1 day
Experiential phenomenological interviews (EPE)
1 day
Depression assessed by Beck Depression Inventory-Second Edition (BDI-II) questionnaire
1 day
Study Arms (1)
Depressive patients
EXPERIMENTALPatients suffering from major depressive disorder with anxiety symptoms
Interventions
Patients will listen to a 30-minute "musical path" of baroque pieces. Before and after this, anxiety, depression and consciousness fluidity will be evaluated thanks to different questionnaires
Eligibility Criteria
You may qualify if:
- Male or female over the age of 18
- Depressive state characterized by the DSM-V criteria
- Able to express his/her consent prior to participation in the study
- Affiliated to or beneficiary of a social security regimen
You may not qualify if:
- Deafness
- Suspected or diagnosed neurodegenerative disorder or other associated neurological pathology
- Comorbid psychotic disorder
- Pregnant women
- Patient under judicial protection (guardianship, curatorship...) or safeguard of justice
- Any other reason that, in the opinion of the investigator, would interfere with the evaluation of the study objectives
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Centre Hospitalier Intercommunal Toulon La Seyne sur Mer
Toulon, Var, 83100, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Manuel Dias Alves, MD
Centre Hospitalier Intercommunal Toulon La Seyne sur Mer
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 19, 2021
First Posted
May 26, 2021
Study Start
May 28, 2021
Primary Completion
February 17, 2022
Study Completion
February 17, 2022
Last Updated
April 13, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share